前入路组织结构分离技术和腹横肌分离技术在腹壁正中巨大切口疝治疗中的应用价值

Application value of anterior component separation and transversus abdominis release technique in the treatment of patients with midline ventral large incisional hernia

  • 摘要: 目的:探讨前入路组织结构分离技术(CST)和腹横肌分离(TAR)技术在腹壁正中巨大切口疝(LIH)治疗中的应用价值。
    方法:采用回顾性横断面研究方法。收集2013年10月至2016年6月上海交通大学医学院附属第九人民医院收治的24例腹壁正中LIH患者的临床资料。患者行开放CST、内镜组织结构分离技术(ECST)或开放TAR加强修补。观察指标:(1)手术学指标:患者手术方式、手术时间、术中出血量、总住院时间。(2)术后并发症。(3)随访情况。采用门诊和电话方式进行随访,了解患者生存情况和切口疝复发情况。随访时间截至2016年6月。正态分布的计量资料以±s表示。
    结果:(1)手术学指标:24例腹壁正中LIH患者均成功完成腹壁缺损的补片加强修复重建,其中14例行开放CST加强修补 (8例传统CST,6例保留腹壁穿支血管神经束的CST);8例行ECST加强修补;2例行开放TAR加强修补。开放CST、ECST、开放TAR加强修补患者手术时间分别为(186±97)min、(209±90)min和(206±21)min;术中出血量分别为(318±108)mL、(251±88)mL和(281±13)mL;总住院时间分别为(18.2±10.0)d、 (22.5±12.9)d和(14.0±2.8)d。(2)术后并发症:14例行开放CST加强修补患者中,术后2例发生血清肿或血肿,2例切口感染,1例切口脂肪液化裂开,均经对症处理后痊愈;8例行ECST加强修补患者中,1例发生肺炎,经对症处理后痊愈;1例发生侧腹壁疝,行开放Sublay补片加强修补术后痊愈;2例行开放TAR加强修补患者均顺利康复,无并发症发生。(3)随访情况:24例患者中,19例获得随访,随访时间为(21±9)个月。随访期间3例患者死亡,其中1例因心肺衰竭死亡,2例因恶性肿瘤术后复发死亡。1例伴切口感染患者术后切口疝复发,再次入院后行开放Sublay补片加强修补术后痊愈。
    结论:基于补片加强的CST是腹壁正中LIH修复重建的重要手段,根据患者的具体情况选择合适手术方式对于提高腹壁正中LIH患者的治疗效果具有重要意义。

     

    Abstract: Objective:To investigate the application value of anterior component separation technique (CST) and transversus abdominis release (TAR) technique in the treatment of patients with midline ventral large incisional hernia (LIH).
    Methods:The retrospective crosssectional study was adopted. The clinical data of 24 patients with midline ventral LIH who were admitted to the Shanghai Ninth People′s Hospital Affiliated to the Shanghai Jiaotong University School of Medicine from October 2013 to June 2016 were collected. The patients underwent reinforced repair with open CST, endoscopic component separation technique (ECST) and open TAR. Observation indices: (1) operative indices: surgical method, operation time, volume of intraoperative blood loss, duration of hospital stay. (2) Postoperative complications. (3) Followup situations. The followup using outpatient examination and telephone interview was conducted to detect patients′ survival and recurrence of incisional hernia up to June 2016. Measurement date with normal distribution were represented as ±s.
    Results :(1) Operative indices: all the 24 patients underwent successful mesh reinforced repair and reconstruction for abdominal wall defects. Of the 24 patients, 14 received reinforced repair with open CST including 8 with open CST and 6 with perforating vessels preserved CST, 8 received reinforced repair with ECST, 2 received reinforced repair with open TAR. The operation time, volume of intraoperative blood loss, duration of hospital stay were (186± 97)minutes, (318±108)mL, (18.2±10.0)days in the patients receiving reinforced repair with open CST and (209±90)minutes, (251±88)mL, (22.5±12.9)days in the patients receiving reinforced repair with ECST and (206±21)minutes, (281±13)mL, (14.0±2.8)days in the patients receiving reinforced repair with open TAR. (2) Postoperative complications: of the 14 patients receiving reinforced repair with open CST, seroma or hematoma were detected in 2 patients, incisional infection in 2 patients, incision separating from fat liquefaction in 1 patient, and they recovered after symptomatic treatments. One patient of pneumonia and 1 of lateral ventral hernia were detected in the 8 patients receiving reinforced repair with ECST, and they recovered after symptomatic treatment and Sublay mesh reimforced repair, respectively. The 2 patients receiving reinforced repair with TAR recovered well without complications. (3)Followup situations: of the 24 patients , 19 were followed up for (21±9)months. During followup, 1 patient died of heartlung failure, 2 died of recurrence of cancer, and 1 patient with incisional infection who was detected to have hernia reccurrence recovered after readmission and Sublay mesh reinforced repair.
    Conclusions: CST with mesh reinforcement is important technique in the repair and reconstruction of midline ventral LIH. Selecting appropriate surgical methods according to individual situation of patients is important to improve therapeutic effects of patients with midline ventral LIH.

     

/

返回文章
返回